424 related articles for article (PubMed ID: 30728452)
1. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins.
Duan Y; Du A; Gu J; Duan G; Wang C; Gui X; Ma Z; Qian B; Deng X; Zhang K; Sun L; Tian K; Zhang Y; Jiang H; Liu C; Fang Y
Cell Res; 2019 Mar; 29(3):233-247. PubMed ID: 30728452
[TBL] [Abstract][Full Text] [Related]
2. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
Liu C; Fang Y
Biochem Pharmacol; 2019 Sep; 167():58-63. PubMed ID: 31034795
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization.
McGurk L; Gomes E; Guo L; Mojsilovic-Petrovic J; Tran V; Kalb RG; Shorter J; Bonini NM
Mol Cell; 2018 Sep; 71(5):703-717.e9. PubMed ID: 30100264
[TBL] [Abstract][Full Text] [Related]
4. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
6. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.
Salapa HE; Hutchinson C; Popescu BF; Levin MC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1214-1224. PubMed ID: 32608162
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.
Sidibé H; Khalfallah Y; Xiao S; Gómez NB; Fakim H; Tank EMH; Di Tomasso G; Bareke E; Aulas A; McKeever PM; Melamed Z; Destroimaisons L; Deshaies JE; Zinman L; Parker JA; Legault P; Tétreault M; Barmada SJ; Robertson J; Vande Velde C
Brain; 2021 Dec; 144(11):3461-3476. PubMed ID: 34115105
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.
Fang MY; Markmiller S; Vu AQ; Javaherian A; Dowdle WE; Jolivet P; Bushway PJ; Castello NA; Baral A; Chan MY; Linsley JW; Linsley D; Mercola M; Finkbeiner S; Lecuyer E; Lewcock JW; Yeo GW
Neuron; 2019 Sep; 103(5):802-819.e11. PubMed ID: 31272829
[TBL] [Abstract][Full Text] [Related]
9. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
[TBL] [Abstract][Full Text] [Related]
10. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
[TBL] [Abstract][Full Text] [Related]
11. ALS and FTD: Where RNA metabolism meets protein quality control.
Mandrioli J; Mediani L; Alberti S; Carra S
Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
[TBL] [Abstract][Full Text] [Related]
12. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
Salapa HE; Johnson C; Hutchinson C; Popescu BF; Levin MC
J Neuroimmunol; 2018 Nov; 324():149-156. PubMed ID: 30190085
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.
Ueda T; Takeuchi T; Fujikake N; Suzuki M; Minakawa EN; Ueyama M; Fujino Y; Kimura N; Nagano S; Yokoseki A; Onodera O; Mochizuki H; Mizuno T; Wada K; Nagai Y
Acta Neuropathol Commun; 2024 Feb; 12(1):20. PubMed ID: 38311779
[TBL] [Abstract][Full Text] [Related]
15. Poly-ADP ribosylation in DNA damage response and cancer therapy.
Hou WH; Chen SH; Yu X
Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
[TBL] [Abstract][Full Text] [Related]
16. Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43).
Romano M; Buratti E; Romano G; Klima R; Del Bel Belluz L; Stuani C; Baralle F; Feiguin F
J Biol Chem; 2014 Mar; 289(10):7121-7130. PubMed ID: 24492607
[TBL] [Abstract][Full Text] [Related]
17. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
McGurk L; Mojsilovic-Petrovic J; Van Deerlin VM; Shorter J; Kalb RG; Lee VM; Trojanowski JQ; Lee EB; Bonini NM
Acta Neuropathol Commun; 2018 Aug; 6(1):84. PubMed ID: 30157956
[TBL] [Abstract][Full Text] [Related]
18. Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties.
Grese ZR; Bastos AC; Mamede LD; French RL; Miller TM; Ayala YM
EMBO Rep; 2021 Dec; 22(12):e53632. PubMed ID: 34787357
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.
Moujalled D; James JL; Yang S; Zhang K; Duncan C; Moujalled DM; Parker SJ; Caragounis A; Lidgerwood G; Turner BJ; Atkin JD; Grubman A; Liddell JR; Proepper C; Boeckers TM; Kanninen KM; Blair I; Crouch PJ; White AR
Hum Mol Genet; 2015 Mar; 24(6):1655-69. PubMed ID: 25410660
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.
He F; Krans A; Freibaum BD; Taylor JP; Todd PK
Hum Mol Genet; 2014 Oct; 23(19):5036-51. PubMed ID: 24920338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
